abstract |
A novel ligand for the ORL-1 receptor is described, which is useful for modulating the activity of the receptor in patients in need of treatment and for the prevention and treatment of diseases that depend on stimulation of the receptor It is. The novel compound is represented by the formula (I) [wherein Q is a moiety represented by the formula (II), and R, R 0 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 are Further defined in the specification]. |